CCL-B Stock Analysis: CCL Industries | TO
Packaging & Containers | TO, Canada | Market Cap: 16.875m CAD | 12M Return: 26.5% | CA1249003098 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.3M
EPS Trend: 97.2%
Qual. Beats: 0
Rev. Trend: 99.0%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
CCL Industries is a Toronto-based materials company that makes pressure-sensitive labels, specialty films, packaging components, printable media, and security and identification solutions. Its products serve consumer packaging, healthcare, retail, automotive, and other markets.
The company operates through four segments: CCL, Avery, Checkpoint, and Innovia. Its business combines converted packaging and labeling materials with RFID and loss-prevention systems, print media, and engineered films-a model that serves customers across multiple industries and regions.
- CCL label growth tracks global consumer packaging and healthcare demand
- Margins hinge on pricing offsetting labor, resin, and energy costs
- Retail RFID adoption supports Checkpoint sales and inventory solutions
| Net Income: 810.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.03 > 1.0 |
| NWC/Revenue: 13.36% < 20% (prev 24.73%; Δ -11.37% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.25b > Net Income 810.6m |
| Net Debt (1.96b) to EBITDA (1.68b): 1.17 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (170.8m) vs 12m ago -3.00% < -2% |
| Gross Margin: 29.81% > 18% (prev 29.82%; Δ -0.01% > 0.5%) |
| Asset Turnover: 74.45% > 50% (prev 73.73%; Δ 0.72% > 0%) |
| Interest Coverage Ratio: 11.94 > 6 (EBIT TTM 1.20b / Interest Expense TTM 100.4m) |
| A: 0.10 (Total Current Assets 3.79b - Total Current Liabilities 2.74b) / Total Assets 11.0b |
| B: 0.42 (Retained Earnings 4.59b / Total Assets 11.0b) |
| C: 0.11 (EBIT TTM 1.20b / Avg Total Assets 10.6b) |
| D: 1.05 (Book Value of Equity 5.66b / Total Liabilities 5.38b) |
| Altman-Z'' = 3.85 = AA |
| DSRI: 1.16 (Receivables 1.71b/1.40b, Revenue 7.89b/7.48b) |
| GMI: 1.00 (GM 29.82% / 29.81%) |
| AQI: 0.94 (AQ_t 0.36 / AQ_t-1 0.38) |
| SGI: 1.05 (Revenue 7.89b / 7.48b) |
| TATA: -0.04 (NI 810.6m - CFO 1.25b) / TA 11.0b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of November 12, 2026, the stock is trading at CAD 101.29 with a total of 900,573 shares traded. Over the past week, the price has changed by +0.86%, over one month by +5.50%, over three months by +10.04% and over the past year by +26.46%.
Current recommended Stop Loss: 98.70 (which is 2.6% or 1.3 ATR below the current price).
CCL Industries has no consensus analysts rating.
P/E Trailing = 20.8828
P/E Forward = 18.0505
P/S = 2.0718
P/B = 2.9641
Revenue TTM = 7.89b CAD
EBIT TTM = 1.20b CAD
EBITDA TTM = 1.68b CAD
Long Term Debt = 1.79b CAD (from longTermDebt, last quarter)
Short Term Debt = 763.0m CAD (from shortTermDebt, last quarter)
Debt = 2.93b CAD (from shortLongTermDebtTotal, last quarter) + Leases 216.2m
Net Debt = 1.96b CAD (calculated: Debt 2.93b - CCE 975.6m)
Enterprise Value = 18.8b CAD (16.9b + Debt 2.93b - CCE 975.6m)
Interest Coverage Ratio = 11.94 (Ebit TTM 1.20b / Interest Expense TTM 100.4m)
EV/FCF = 22.83x (Enterprise Value 18.8b / FCF TTM 825.1m)
FCF Yield = 4.38% (FCF TTM 825.1m / Enterprise Value 18.8b)
FCF Margin = 10.46% (FCF TTM 825.1m / Revenue TTM 7.89b)
Net Margin = 10.27% (Net Income TTM 810.6m / Revenue TTM 7.89b)
Gross Margin = 29.81% ((Revenue TTM 7.89b - Cost of Revenue TTM 5.54b) / Revenue TTM)
Gross Margin QoQ = 29.92% (prev 30.19%)
Tobins Q-Ratio = 1.70 (Enterprise Value 18.8b / Total Assets 11.0b)
Interest Expense / Debt = 3.42% (Interest Expense 100.4m / Debt 2.93b)
Taxrate = 26.18% (287.5m / 1.10b)
NOPAT = 884.9m (EBIT 1.20b * (1 - 26.18%))
Current Ratio = 1.39 (Total Current Assets 3.79b / Total Current Liabilities 2.74b)
Debt / Equity = 0.52 (Debt 2.93b / totalStockholderEquity, last quarter 5.66b)
Debt / EBITDA = 1.17 (Net Debt 1.96b / EBITDA 1.68b)
Debt / FCF = 2.37 (Net Debt 1.96b / FCF TTM 825.1m)
Total Stockholder Equity = 5.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 810.6m / Total Assets 11.0b)
RoE = 14.41% (Net Income TTM 810.6m / Total Stockholder Equity 5.62b)
RoCE = 16.17% (EBIT 1.20b / Capital Employed (Equity 5.62b + L.T.Debt 1.79b))
RoIC = 10.20% (NOPAT 884.9m / Invested Capital 8.68b)
WACC = 5.58% (E(16.9b)/V(19.8b) * Re(6.11%) + D(2.93b)/V(19.8b) * Rd(3.42%) * (1-Tc(0.26)))
Discount Rate = 6.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.59 | Cagr: -2.18%
[DCF] Terminal Value 76.58% ; FCFF base≈797.2m ; Y1≈861.6m ; Y5≈1.06b
[DCF] Fair Price = 90.54 (EV 16.2b - Net Debt 1.96b = Equity 14.2b / Shares 157.3m; r=8.35% [WACC [floored]]; 5y FCF grow 9.23% → 2.50% )
EPS Correlation: 97.20 | EPS CAGR: 9.22% | SUE: 0.72 | # QB: 0
Revenue Correlation: 99.01 | Revenue CAGR: 7.08% | SUE: 3.07 | # QB: 1
EPS current Quarter (2027-03-31): EPS=1.31 | Chg30d=-0.47% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=5.08 | Chg30d=-0.22% | Revisions=-25% | GrowthEPS=+10.1% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=5.45 | Chg30d=-0.27% | Revisions=-29% | GrowthEPS=+7.3% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +0% (up=4, down=4)